featured
Combination of Everolimus With Trastuzumab Plus Paclitaxel in First-Line Treatment of HER2+ Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Combination of Everolimus With Trastuzumab Plus Paclitaxel as First-Line Treatment for Patients With HER2-Positive Advanced Breast Cancer (BOLERO-1): A Phase 3, Randomised, Double-Blind, Multicentre Trial
Lancet Oncol 2015 Jun 16;[EPub Ahead of Print], SA Hurvitz, F Andre, Z Jiang, Z Shao, MS Mano, SP Neciosup, LM Tseng, Q Zhang, K Shen, D Liu, LM Dreosti, HA Burris, M Toi, ME Buyse, D Cabaribere, MA Lindsay, S Rao, LB Pacaud, T Taran, D SlamonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.